Baxter International Inc., founded in 1931 and headquartered in Deerfield, Illinois, is a global healthcare company focused on providing innovative medical products and therapies aimed at saving and sustaining lives. The company specializes in a wide range of areas, including renal care, medication delivery, and surgical devices, offering essential solutions for patients and healthcare providers worldwide.
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Baxter has a history of bond issuances dating back to the 1980s, establishing a presence in the debt markets to fund its operations and acquisitions. Notably, the company issued a significant $1.2 billion bond in 2020 to finance its acquisition of a leading provider of renal care products, enhancing its portfolio. Current yields on Baxter’s bonds are competitive within the healthcare sector, reflecting investor confidence, while certain issues feature call options, providing flexibility for the company in managing debt. Recent market data indicates strong demand for Baxter’s bonds, particularly amid ongoing healthcare investments.